Volume and Heterogeneity Dependence of the Dose-Response Relationship for Head And Neck Tumours

References

• Cohen L. The statistical prognosis in radiation therapy. Am J Roentgenol 1960; 84: 741–53
   Web of Science ®Google Scholar
• Brahme A. Dosimetric precision requirements in radiation therapy. Acta Radiol Oncol 1984; 23: 379–91
   PubMed Web of Science ®Google Scholar
• Källman P, Ågren A ‐K, Brahme A. Tumor and normal tissue responses to fractionated non uniform dose delivery. Int J Radiat Biol 1992; 62: 249–62
   PubMed Web of Science ®Google Scholar
• Shukovsky L J. Dose, time, volume relationships in squamous cell carcinoma of the supraglottic larynx. Am J Roentgenol 1970; 108: 27–9
   Web of Science ®Google Scholar
• Stewart J G, Jackson A W. The steepness of the dose‐response curve both for tumor cure and normal tissue injury. Laryngoscope 1975; 85: 1107–11
   PubMedGoogle Scholar
• Jenkin R D T, Anderson J R, Jereb B, et al. Nasopharyngeal carcinoma‐A retrospective review of patients less than thirty years of age. A report from Childrens Cancer Study Group. Cancer 1981; 47: 360–6
   PubMedGoogle Scholar
• Harwood A R, Beale F A, Cummings B J, et al. Supraglottic laryngeal carcinoma: an analysis of dose‐time‐ volume factors in 410 patients. Int J Radiat Oncol Biol Phys 1983; 9: 311–9
   PubMed Web of Science ®Google Scholar
• Turesson I, Brahme A. Clinical rationale for high precision radiotherapy. ESTRO, Malmö 1992
   Google Scholar
• Withers H R. Biological basis of radiation therapy. Principles and practice of radiation oncology, C A Perez, L W Brady. JB Lippincott, Philadelphia 1992; 67–98
   Google Scholar
• Brahme A. Treatment optimization using physical and biological objective functions. Radiation therapy physics, A Smith. Springer‐Verlag, Berlin 1995
   Google Scholar
• Söderström S, Brahme A. Which is the most suitable number of photon beam portals in coplanar radiation therapy. Int J Radiat Oncol Biol Phys 1995, (in press)
   PubMedGoogle Scholar
• Ågren A ‐K, Brahme A, Turesson I. Optimization of uncomplicated control for head and neck tumors. Int J Radiat Oncol Biol Phys 1990; 19: 1077–85
   PubMed Web of Science ®Google Scholar
• Wolbarst A B. Optimization of radiation therapy II: The critical‐voxel model. Int J Radiat Oncol Biol Phys 1984; 10: 741–5
   PubMed Web of Science ®Google Scholar
• Brahme Ågren A. On the optimal dose distribution for eradication of heterogeneous tumors. Acta Oncol 1987; 26: 377–85
   PubMed Web of Science ®Google Scholar
• Brahme A, Källman P, Tilikidis A. Developments in ion beam therapy planning and treatment optimization. Ion beam therapy, U Linz. Chapman & Hall. 1994
   Google Scholar
• Ågren A ‐K, Källman P, Brahme A. Determination of the relative seriality of a tissue from its response to non‐uniform dose delivery. Modelling in clinical radiobiology, D Baltas, 1994, (In press)
   Google Scholar
• Dutreix J, Tubiana M, Dutreix A. An approach to the interpretation of clinical data on the tumour control probability‐dose relationship. Radiother Oncol 1988; 11: 239–48
   PubMed Web of Science ®Google Scholar
• Brahme A. Accuracy requirements and quality assurance of external beam therapy with photons and electrons. Acta Oncol 1988, Suppl. 1: 5–76
   Google Scholar
• Tilikidis A, Brahme A. Microdosimetric description of beam quality and biological effectiveness in radiation therapy. Acta Oncol 1994; 33: 457–69
   PubMed Web of Science ®Google Scholar
• Lindborg L, Brahme A. Influence of microdosimetric quantities on observed dose‐response relationships in radiation therapy. Radiat Res 1990; 124: 23–8
   PubMed Web of Science ®Google Scholar
• Travis E L, Tucker S L. Isoeffect models and fractionated radiation therapy. Int J Radiat Oncol Biol Phys 1987; 13: 283–7
   PubMedGoogle Scholar
• Slevin N J, Hendry J H, Roberts S A, Ågren‐Cronqvist A. The effect of increasing the treatment time beyond three weeks on the control of T2 and T3 laryngeal cancer using radiotherapy. Radiother Oncol 1992; 24: 215–20
   PubMed Web of Science ®Google Scholar
• Hendry J H, Roberts S A, Slevin N J, Keane T J, Barton M B, Ågren‐Cronqvist A. Influence of radiotherapy treatment time on control of laryngeal cancer: comparisons between centres in Manchester, UK and Toronto, Canada. Radiother Oncol 1994; 31: 14–22
   PubMed Web of Science ®Google Scholar
• Hendry J H. Treatment acceleration in radiotherapy: the relative time factors and dose‐response slopes for tumours and normal tissues. Radiat Oncol 1992; 25: 308–12
   Google Scholar
• Thames H D, Peters L J, Spanos W, Fletcher G F. Dose‐response of squamous cell carcinomas of the upper respiratory and digestive tracts. Br J Cancer 1980; 41(Suppl. IV)35–8
   Google Scholar
• Hjelm‐Hansen M, Jørgensen K, Andersen A P, Lund C. Laryngeal carcinoma II. Analysis of treatment results using the Ellis model. Acta Radiol 1979; 18: 385–407
   Google Scholar
• Robertson A G, Robertson C, Boyle P, Symonds R P, Wheldon T E. The effect of differing radiotherapeutic schedules on the response of glottic carcinoma of the larynx. Eur J Cancer 1993; 29A: 501–10
   PubMed Web of Science ®Google Scholar
• Aristizabal S A, Caldwell W L. Radiation tolerance of the normal tissues of the larynx. Radiology 1972; 130: 419–22
   Google Scholar
• Thames H D, Schultheiss T E, Tucker S L, Dubray B M, Hendry J H, Brock W A. Can modest escalations of dose be detected as increased tumor control? Int J Radiat Oncol Biol Phys 1992; 22: 241–6
   PubMed Web of Science ®Google Scholar
• Kim J ‐C, Elkin D, Hendrickson F R. Carcinoma of the vocal cord. Results of treatment and time‐dose relationships. Cancer 1978; 42: 1114–9
   PubMed Web of Science ®Google Scholar
• Withers H R, Taylor J M G, Maciejewski B. The hazard of accelerated tumor clonogen repopulation during radiotherapy. Acta Oncol 1988; 27: 131–46
   PubMed Web of Science ®Google Scholar
• Bedwinek J M, Perez C A, Keys D J. Analysis of failures after definitive irradiation for epidermoid carcinoma of the nasopharynx. Cancer 1980; 45: 2725–9
   PubMed Web of Science ®Google Scholar
• Metz C E, Tokars R P, Kronman H B, Griem M L. Maximum likelihood estimation of dose‐response parameters for therapeutic operating characteristic (TOC) analysis of carcinoma of the nasopharynx. Int J Radiat Oncol Biol Phys 1982; 8: 1185–92
   PubMed Web of Science ®Google Scholar
• Tokars R P, Griem M L. Carcinoma of the nasopharynx an optimization of radiotherapeutic management for tumor control and spinal cord injury. Int J Radiat Oncol Biol Phys 1979; 5: 1741–8
   PubMedGoogle Scholar
• Yan J H, Qin D X, Hu Y H, et al. Management of local residual primary lesion of nasopharyngeal carcinoma (NPC): Are higher doses beneficial? Int J Radiat Oncol Biol Phys 1989; 16: 1465–9
   Google Scholar
• Cohen L. Absence of a demonstrable gain factor for neutron beam therapy of epidermoid carcinoma of the head and neck. Int J Radiat Oncol Biol Phys 1982; 8: 2173–6
   PubMed Web of Science ®Google Scholar